- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
In Hong Kong, the number of HIV cases transmitted through injecting drug use (IDU) has remained low up till now and contributed to less than 5% of all reported cases cumulatively. However, the potential risk of cluster outbreak and rapid upsurge of infection among the IDU population is always a concern. To monitor HIV-related risk behaviours and access to HIV testing services among IDU, this population has been included as one of the four at-risk populations in the HIV/AIDS Response Indicator Survey (HARiS) implemented since 2013. The sixth round of survey was conducted in 2018 via commissioning to the Stanley Ho Centre for Emerging Infectious Disease, School of Public Health and Primary Care of the Chinese University of Hong Kong.
Keywords: HIV, IDU, drug, testing, condom use, needle
Countries in Asia implement some of the harshest drug policies in the world. As United Nations (UN) member states are set to meet in March 2019 to take stock of progress made since 2009 and delineate the next phase for global drug policy, ‘10 Years of Drug Policy in Asia: How Far Have We Come?’ evaluates the impacts of drug policies in Asia over the past decade from a civil society perspective. The critical role of civil society in the design, implementation, monitoring and evaluation of drug policies is acknowledged in the 2009 Political Declaration and Plan of Action, as well as in the Outcome Document of the 2016 United Nations General Assembly Special Session (UNGASS) on drugs. Using data from the UN, academic literature and contributions from civil society, this report aims to provide a critical assessment of drug policy failures and successes across the region, with the aim of informing high-level discussions on the next decade of drug policy.
Girls and women make up more than half of the 36.9 million people living with HIV. Ending AIDS by 2030 requires that we address girls’ and women’s diverse roles by putting them at the centre of the response.
Keywords: HIV, women, girls, response
Significant progress has been made to curb the HIV/AIDS epidemic in PNG. However, the country has the highest HIV prevalence and rate of new infections in the Asia and Pacific region. No nationwide population-based survey has been conducted to measure the true burden of the disease in the country. Estimates based on anti-natal care (ANC) attendances using Spectrum put the prevalence of HIV among adults 15 – 49 years at 0.9% (0.7 – 1.0) in 2017.
Nepali women and girls are vulnerable to violence at the hands of their husbands and in-laws. The key drivers of women’s vulnerability to violence against women and girls (VAWG) in the migrant communities of Nepal include gender inequitable norms, the lower position of young married women in the family, poor spousal and in-law relations, and poverty. In this context, working with the family has great potential to reduce violence and improve the conditions of women and girls.
This Guide provides a conceptual and methodological framework for National Human Rights Institutions conducting country assessments and public inquiries in the context of sexual and reproductive health. The Guide aims to help develop more comprehensive information systems on human rights in the context of sexual and reproductive health, but also to ensure a standardized approach to the assessment of human rights violations in this area. Through featuring experiences from Azerbaijan, El Salvador, Guatemala, Malawi and the Philippines, the Guide illustrates how these frameworks translate into practice.
The report proposes a framework of four synergistic elements necessary to advance inclusion, empowerment and equality: rights and justice; norms and institutions; resources and capabilities; participation and voice. The need for action on all four fronts is illustrated by a deeper look at three pivotal challenges confronted by the region – (1) climate change and its potential to deepen inequality; (2) the urgent need to boost domestic resource mobilization; and (3) the need to strengthen social accountability and civic engagement. It draws out policy messages on how an empowerment-and-inclusion approach to policymaking can be fostered, including on addressing violence against women and girls. The report provides strong evidence that promoting empowerment and inclusion are necessary approaches to reduce inequality and accelerate progress towards a broad array of Sustainable Development Goals. It is a contribution to the ongoing national, regional and global dialogues on opportunities to empower people, ensure their inclusion and advance equality.
WHO estimates that 71 million people worldwide were chronically infected with hepatitis C virus (HCV) in 2017. Globally, 23% of new HCV infections and one in three HCV deaths are attributable to injecting drug use (PWID). HCV is also a major concern for people detained in prisons and other closed settings – available data demonstrate that one in four detainees are HCV positive.
This policy brief highlights the current landscape of country hepatitis policies for harm reduction and HCV testing and treatment in PWID and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis, 2016-2021 into national plans, and provides a summary of the enablers and barriers to HCV testing and treatment in these populations.
Laws that discriminate can be changed. To do so, people need to know their rights, make discrimination visible and mobilize support and the effective use of legal means. Below are some steps and actions that you can take to change discriminatory laws.
The National STD/AIDS Control Programme (NSACP) of the Ministry of Health is the main government organization which coordinate the national response to sexually transmitted infections including HIV/AIDS in Sri Lanka. It collaborates with many national and international organizations such as the Global Fund to Fight Against AIDS, TB and Malaria (GFATM) and UN organizations while providing leadership and technical support to 33 island wide STD clinics and 21 ART centers. Furthermore, it provides quality STI and HIV laboratory services through a comprehensive laboratory network. National and subnational level monitoring and evaluation and surveillance are other important activities carried out by NSACP.